NVG-2089 clinical trials

A Phase 2, Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous NVG-2089 in Participants with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

This study is testing a new medicine called NVG-2089 for a nerve condition called CIDP. It's looking at how safe the medicine is, if people can tolerate it, and if it helps improve CIDP symptoms. It includes people new to treatment and those who've tried other things.